Back

Transcriptional reprogramming by IL-2 variant generates metabolically active stem-like T cells

Ortiz Miranda, Y.; Masid, M.; Jimenez-Luna, C.; Montalvo Bereau, G. M.; Muller, T.; Rayroux, N.; Cribioli, E.; Corria-Osorio, J.; Carrasco Hope, H.; Vuillefroy de Silly, R.; Seijo, B.; Ginefra, P.; Leon, K.; Vannini, N.; Ho, P.-C.; Crespo, I.; Hatzimanikatis, V.; Irving, M.; Coukos, G.

2023-05-24 systems biology
10.1101/2023.05.24.541283 bioRxiv
Show abstract

Interleukin-2 receptor (IL-2R)-mediated intracellular signaling is a key regulator of T-cell fate decisions. While the potent signals generated by IL-2 engagement execute effector differentiation, elevated metabolic activities and rapid cellular expansion, IL-15 binding induces a stemness/memory phenotype and a quiescent metabolic state. Here, we demonstrate that weak but sustained signaling generated by a non-IL-2R-binding variant of IL-2 (IL-2v) drive proliferation/metabolic and stemness transcriptional programs, thereby reprogramming CD8+ T cells into a hybrid metabolically active stem-like state. We further show that IL-2v-induced T cells are capable of superior engraftment, persistence, and tumor control when utilized in adoptive cell therapy. Taken together, our study highlights the ability to fine-tune cytokine engagement of cognate receptors in order to generate therapeutically relevant T-cell states and further reveals the metabolic plasticity of the T-cell memory program.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.